I-MAB BIOPHARMA
I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. .
I-MAB BIOPHARMA
Social Links:
Industry:
Biotechnology Pharmaceutical Product Research
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.i-mabbiopharma.com
Total Employee:
51+
Status:
Active
Contact:
+862160578000
Email Addresses:
[email protected]
Total Funding:
815 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx IPv6 Microsoft Azure DNS
Similar Organizations
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Visen Pharmaceuticals
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-03-23 | Tianjing Biotechnology (Shanghai) Co | Tianjing Biotechnology (Shanghai) Co acquired by I-Mab Biopharma | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - I-Mab Biopharma
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - I-Mab Biopharma
Alyeska Investment Group
Alyeska Investment Group investment in Post-IPO Equity - I-Mab Biopharma
Avidity Partners
Avidity Partners investment in Post-IPO Equity - I-Mab Biopharma
Lake Bleu Capital
Lake Bleu Capital investment in Post-IPO Equity - I-Mab Biopharma
OrbiMed
OrbiMed investment in Post-IPO Equity - I-Mab Biopharma
GIC
GIC investment in Post-IPO Equity - I-Mab Biopharma
Octagon Capital Partners
Octagon Capital Partners investment in Post-IPO Equity - I-Mab Biopharma
Invus
Invus investment in Post-IPO Equity - I-Mab Biopharma
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - I-Mab Biopharma
Official Site Inspections
http://www.i-mabbiopharma.com Semrush global rank: 3.35 M Semrush visits lastest month: 4.74 K
- Host name: 47.102.217.73
- IP address: 47.102.217.73
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
